Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals ...

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended ...

UTI-Small Cap Fund - Direct (IDCW) 76.25 26,32,593 1.68 UTI-Small Cap Fund - Direct (G) 76.25 26,32,593 1.68 UTI-Small Cap Fund (IDCW) 76.25 26,32,593 1.68 UTI-Small Cap Fund (G) 76.25 26,32,593 1.68 ...

News for Marksans Pharma Ltd. Vanguard Group Buys Rs 998 Cr Shares in 7 Companies Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including ...

The Quarterly Results page of Marksans Pharma Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Featured here, the Income Statement (earnings report) for Marksans Pharma Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness products. From anti-estrogen aids to peptides and post-cycle therapy ...

Verona Pharma ( (VRNA)) has released its Q3 earnings. Here is a breakdown of the information Verona Pharma presented to its investors. Verona Pharma, a biopharmaceutical company focused on chronic ...